Skip to content
Menu

Co-Diagnostics, Inc. CODX

Full chart Compare
Set alert

Price alert · CODX

All alert types
0.13 USD -0.04 (-21.32%)

Regular-session close

0.14 +0.01 +5.95%

After hours · Nov 20, 7:41 PM ET

0.1276 Day range 0.1421
0.1295 52-week range 11.61
YTD
-97.45%
1 year
-98.66%

5D -0.1015 (-43.94%)

0.15000.20000.2500MonTueWedThuFri0.1295
Market cap
1.36M
Revenue (ttm)
7.32M
EPS (ttm)
-21.71
Shares out
31.93M
Forward P/E
-0.62
YTD return
-97.45%
1-year return
-98.66%
50-day average
1.06
Volume
1.14M
Avg volume
2.01M
Open
0.14
Previous close
0.1646
Day's range
0.1276 – 0.1421
52-week range
0.1295 – 11.61
Beta
-0.85
Price target
1.50 (+1058.3%)

Key statistics

200-day average
1.19
Enterprise value
-11.98M
Price / sales
3.18
Price / book
0.36
Revenue growth
-73.90%
Free cash flow
-12.79M
Total cash
37.66M
Total debt
2.37M
Return on equity
-50.57%
Short % of float
0.76%

Fundamental scorecard

6 of 25 checks passed on CODX’s reported financials

ValueGrowthProfitabilityHealthDividend

6of 25 checks passed

  • Value 2 of 5
  • Growth 2 of 5
  • Profitability 0 of 5
  • Financial health 2 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
CODX Revenue — quarterly 282.88K
CODX Net income — quarterly -6.31M
CODX EPS — quarterly -1.01

Earnings

CODX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.33-0.32+0.01+3.03%
Aug 8, 2024Jun 1, 2024-0.34-0.25+0.09+26.47%
Aug 8, 2024Jun 1, 2024-0.34———
May 9, 2024Mar 1, 2024-0.21-0.31-0.10-47.62%
May 9, 2024Mar 1, 2024-0.21———
Mar 14, 2024Dec 1, 20230.00-0.50——

Upgrades / downgrades

CODX analyst upgrades and downgrades
DateFirmActionFromTo
Nov 11, 2024HC Wainwright & Co.reitNeutralNeutral
Aug 12, 2024HC Wainwright & Co.mainNeutralNeutral
Jun 17, 2024HC Wainwright & Co.reitNeutralNeutral
May 13, 2024HC Wainwright & Co.mainNeutralNeutral
Mar 15, 2024HC Wainwright & Co.mainNeutralNeutral
Dec 29, 2023HC Wainwright & Co.reitNeutralNeutral

About Co-Diagnostics, Inc.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on CODX — it syncs with the Stock Master app.

Insider holders

CODX insider holders
InsiderRelationLatest transactionDateShares held
ABBOTT RICHARD DAVIDPresidentStock Award(Grant)Nov 21, 202413,915
BROWN BRIAN LEEChief Financial OfficerStock Award(Grant)Nov 21, 2024419,905
DURENARD EUGENE ADirectorConversion of Exercise of derivative securityNov 21, 2024163,333
EGAN DWIGHT H.Chief Executive OfficerConversion of Exercise of derivative securityNov 21, 2024522,858
MURPHY TEDDirectorConversion of Exercise of derivative securityNov 21, 2024175,833
NELSON JAMES BDirectorConversion of Exercise of derivative securityNov 21, 2024163,333

Institution ownership

CODX institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc5.58%1,781,2831.30MSep 29, 2024
Renaissance Technologies, LLC1.78%567,722413.93KSep 29, 2024
Blackrock Inc.1.58%504,382367.74KSep 29, 2024
Geode Capital Management, LLC1.01%321,275234.24KSep 29, 2024
Bridgeway Capital Management, Inc.0.85%272,900198.97KSep 29, 2024
Susquehanna International Group, LLP0.59%187,569136.76KSep 29, 2024

Fund ownership

CODX fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund4.01%1,279,125932.61KSep 29, 2024
Vanguard Extended Market Index Fund1.39%444,776324.29KSep 29, 2024
Bridgeway Funds Inc-Ultra Small Company Fund0.85%272,900198.97KSep 29, 2024
Fidelity Extended Market Index Fund0.54%172,056125.45KOct 30, 2024
iShares Micro Cap ETF0.22%69,77050.87KOct 30, 2024
Fidelity Total Market Index Fund0.17%53,20138.79KOct 30, 2024